ArticleNPJ precision oncology2026
Real-world benchmarking and validation of foundation model transformers for endometrial cancer subtyping from histopathology.
Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer.International journal of molecular sciences · 2026Review
- AI-assisted histomorphological stratification of endometrial cancer: real-world validation of foundation models for molecular subtyping.NPJ precision oncology · 2026Article
- Foundation models in healthcare: a comprehensive review from technical advances to clinical translation.Journal of translational medicine · 2026Review
Corrections and comments
- Update of
- Update of
Authors and funding
7 authors.
Funding
Abstract
We benchmarked histopathology foundation encoders paired with attention-based multiple instance learning (MIL) against convolutional neural networks (CNNs) to assess their robustness for endometrial cancer molecular classification (MMR-deficient, p53 aberrant, POLE pathogenic mutation, and no specific molecular profile) from whole-slide images (WSIs) in a real-world cohort. A public cohort of 815 patients (1195 WSIs) was assembled for model development. Generalizability was evaluated using an external cohort of 720 patients (1357 WSIs). Models were trained using five-fold cross-validation and tested on the external cohort. Performance was summarized using macro-area under the receiver operating characteristic curve (AUC), macro-F1 score, and balanced accuracy. In cross-validation, foundation encoder models outperformed CNNs (macro-AUC 0.799-0.860 vs 0.715-0.829). The best configuration (Virchow2 with CLAM MIL) achieved macro-AUC 0.860, macro-F1 score 0.607, and balanced accuracy 0.647. On external validation, CNN performance degraded substantially, whereas foundation models retained higher discrimination. UNI2 with CLAM MIL achieved the highest external macro-AUC 0.780 with a macro-F1 score of 0.416 and balanced accuracy of 0.507. Subtype-level performance was highest for p53abn (AUC 0.851). When evaluated within a benchmarking framework, foundation encoders paired with attention-based MIL demonstrate improved generalization for endometrial cancer molecular subtyping from WSIs compared with CNNs, supporting their potential for subtype inference.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.